替加環素成功治療肺感染廣泛耐藥肺炎克雷伯菌一例_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

劉元明 , 王茂筠 ,  梁宗安

四川大學華西醫院呼吸與危重癥醫學科(四川成都 610041);

Corresponding?author：

梁宗安, Email: liang.zongan@163.com

Keywords：

DOI：

10.7507/1671-6205.2014127

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 劉元明, 王茂筠, 梁宗安. 替加環素成功治療肺感染廣泛耐藥肺炎克雷伯菌一例. Chinese Journal of Respiratory and Critical Care Medicine, 2014, 13(5): 521-522. doi: 10.7507/1671-6205.2014127 Copy

1.	俞云松.超廣譜β-內酰胺酶研究進展.中華醫學雜志, 2006, 86:641-644.
2.	Kitchel B, Rasheed JK, Patel JB, et al.Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States:clonal expansion of multilocus sequence type 258.Antimicrob Agents Chemother, 2009, 53:3365-3370.
3.	Wei ZQ, Du XX, Yu YS, et al.Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.Antimicrob Agents Chemother, 2007, 51:763-765.
4.	湯瑾, 李卿, 蔣燕群.對肺炎克雷伯菌碳青霉烯酶的研究進展.檢驗醫學, 2010, 25:63-66.
5.	李春輝, 吳安華.醫療機構耐藥菌MDR、XDR、PDR的國際標準化定義專家建議(草案).中國感染控制雜志, 2011, 10:238-240.
6.	Nordmann P, Cuzon G, Naas T.The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.Lancet Infect Dis, 2009, 9:228-236.
7.	Falagas ME, Kastoris AC, Kapaskelis AM, et al.Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections:a systematic review.Lancet Infect Dis, 2010, 10:43-50.
8.	Elemam A, Rahimian J, Mandell W.Infection with panresistant Klebsiella pneumoniae:a report of 2 cases and a brief review of the literature.Clin Infect Dis, 2009, 49:271-274.
9.	許明, 林陳水, 付水星.替加環素的抗菌作用及藥理學性質.國外醫藥(抗生素分冊), 2006, 27:250-254.

1. 俞云松.超廣譜β-內酰胺酶研究進展.中華醫學雜志, 2006, 86:641-644.
2. Kitchel B, Rasheed JK, Patel JB, et al.Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States:clonal expansion of multilocus sequence type 258.Antimicrob Agents Chemother, 2009, 53:3365-3370.
3. Wei ZQ, Du XX, Yu YS, et al.Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.Antimicrob Agents Chemother, 2007, 51:763-765.
4. 湯瑾, 李卿, 蔣燕群.對肺炎克雷伯菌碳青霉烯酶的研究進展.檢驗醫學, 2010, 25:63-66.
5. 李春輝, 吳安華.醫療機構耐藥菌MDR、XDR、PDR的國際標準化定義專家建議(草案).中國感染控制雜志, 2011, 10:238-240.
6. Nordmann P, Cuzon G, Naas T.The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.Lancet Infect Dis, 2009, 9:228-236.
7. Falagas ME, Kastoris AC, Kapaskelis AM, et al.Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections:a systematic review.Lancet Infect Dis, 2010, 10:43-50.
8. Elemam A, Rahimian J, Mandell W.Infection with panresistant Klebsiella pneumoniae:a report of 2 cases and a brief review of the literature.Clin Infect Dis, 2009, 49:271-274.
9. 許明, 林陳水, 付水星.替加環素的抗菌作用及藥理學性質.國外醫藥(抗生素分冊), 2006, 27:250-254.

Previous Article
嚴重口腔結核合并慢性血行播散型肺結核一例
Next Article
單克隆抗體在難治性哮喘中的治療進展

Chinese Journal of Respiratory and Critical Care Medicine

替加環素成功治療肺感染廣泛耐藥肺炎克雷伯菌一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content